Anna di Luca Sidozzi

National Cancer Institute

Papers

1

Total Citations

25

H-Index

1

About

Anna di Luca Sidozzi is a leading figure in gynecologic oncology, with a focused expertise in advancing minimally invasive surgical techniques for the treatment of endometrial cancer. Her most cited work, a 2016 case-control study, directly compares robotic single-site hysterectomy (RSSH) to the conventional robotic multiport approach (RMPH) in early-stage endometrial cancer. This pivotal research, accumulating 25 citations, systematically evaluates not only perioperative outcomes but also the critical economic implications of these two robotic platforms. By rigorously analyzing surgical efficacy alongside cost-effectiveness, Dr. Sidozzi provides essential data that helps shape clinical decision-making and resource allocation in robotic surgery. Her contributions are particularly significant for surgeons and institutions seeking to optimize patient recovery and reduce surgical morbidity without compromising oncologic safety. Through this landmark study, she has established a benchmark for comparing novel single-site technologies against established multiport methods, offering a balanced, evidence-based perspective that directly influences the evolution of surgical practice in gynecologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
25
Total Citations
25
Avg Citations/Paper
🏆 Most Cited Paper
Robotic single site versus robotic multiport hysterectomy in early endometrial cancer: a case control study
25 citations · 2016
📈 Most Prolific Year: 2016 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: National Cancer Institute

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago